semaglutide risks The obesity drug (Wegovy) conferred a significantly higher risk of ischemic optic neuropathy (ION) than any other GLP-1 agonist, including semaglutide for diabetes (Ozempic), an analysis of FDA data showed. Added The Risks of Compounded Semaglutide

Research Applications May Include : Studies on neuroprotection and cognitive function Exploration of BDNF modulation Investigations into stroke recovery and brain injury models Protected: SS-31 Tesamorelin Tesamorelin Tesamorelin 10mg (Lyophilized Peptide) For Research Use Only Tesamorelin is a synthetic peptide analog of Growth Hormone-Releasing Hormone (GHRH), studied for its potential to stimulate endogenous growth hormone secretion in controlled research environments

Cardiovascular and Metabolic Benefits : Semaglutide, as demonstrated in the SELECT trial, has established long-term cardiovascular benefits, with an average weight loss of 10.2% over four years, highlighting its role in cardiometabolic risk reduction

You can customize any therapy to fit your wellness goals

Hepatic GCGR activation stimulates gluconeogenesis while simultaneously reducing hepatic fat content through inhibition of de novo lipogenesis and promotion of mitochondrial fatty acid oxidation